These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

205 related articles for article (PubMed ID: 24604750)

  • 1. Fractionated stereotactic radiotherapy to the post-operative cavity for radioresistant and radiosensitive brain metastases.
    Ahmed KA; Freilich JM; Abuodeh Y; Figura N; Patel N; Sarangkasiri S; Chinnaiyan P; Yu HH; Etame AB; Rao NG
    J Neurooncol; 2014 May; 118(1):179-86. PubMed ID: 24604750
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Potential role for LINAC-based stereotactic radiosurgery for the treatment of 5 or more radioresistant melanoma brain metastases.
    Frakes JM; Figura NB; Ahmed KA; Juan TH; Patel N; Latifi K; Sarangkasiri S; Strom TJ; Chinnaiyan P; Rao NG; Etame AB
    J Neurosurg; 2015 Nov; 123(5):1261-7. PubMed ID: 26140482
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Radiosurgery or hypofractionated stereotactic radiotherapy for brain metastases from radioresistant primaries (melanoma and renal cancer).
    Lesueur P; Lequesne J; Barraux V; Kao W; Geffrelot J; Grellard JM; Habrand JL; Emery E; Marie B; Thariat J; Stefan D
    Radiat Oncol; 2018 Jul; 13(1):138. PubMed ID: 30055640
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impact of 2-staged stereotactic radiosurgery for treatment of brain metastases ≥ 2 cm.
    Angelov L; Mohammadi AM; Bennett EE; Abbassy M; Elson P; Chao ST; Montgomery JS; Habboub G; Vogelbaum MA; Suh JH; Murphy ES; Ahluwalia MS; Nagel SJ; Barnett GH
    J Neurosurg; 2018 Aug; 129(2):366-382. PubMed ID: 28937324
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impact of adjuvant fractionated stereotactic radiotherapy dose on local control of brain metastases.
    Musunuru HB; Witt JS; Yadav P; Francis DM; Kuczmarska-Haas A; Labby ZE; Bassetti MF; Howard SP; Baschnagel AM
    J Neurooncol; 2019 Nov; 145(2):385-390. PubMed ID: 31606876
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Outcomes Following Hypofractionated Stereotactic Radiotherapy in the Management of Brain Metastases.
    Ahmed KA; Sarangkasiri S; Chinnaiyan P; Sahebjam S; Yu HH; Etame AB; Rao NG
    Am J Clin Oncol; 2016 Aug; 39(4):379-83. PubMed ID: 24755663
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Outcome variation among "radioresistant" brain metastases treated with stereotactic radiosurgery.
    Chang EL; Selek U; Hassenbusch SJ; Maor MH; Allen PK; Mahajan A; Sawaya R; Woo SY
    Neurosurgery; 2005 May; 56(5):936-45; discussion 936-45. PubMed ID: 15854241
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Stereotactic radiosurgery to the resection bed for intracranial metastases and risk of leptomeningeal carcinomatosis.
    Ojerholm E; Lee JY; Thawani JP; Miller D; O'Rourke DM; Dorsey JF; Geiger GA; Nagda S; Kolker JD; Lustig RA; Alonso-Basanta M
    J Neurosurg; 2014 Dec; 121 Suppl():75-83. PubMed ID: 25434940
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Multidose stereotactic radiosurgery (9 Gy × 3) of the postoperative resection cavity for treatment of large brain metastases.
    Minniti G; Esposito V; Clarke E; Scaringi C; Lanzetta G; Salvati M; Raco A; Bozzao A; Maurizi Enrici R
    Int J Radiat Oncol Biol Phys; 2013 Jul; 86(4):623-9. PubMed ID: 23683828
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Local progression and pseudo progression after single fraction or fractionated stereotactic radiotherapy for large brain metastases. A single centre study.
    Wiggenraad R; Verbeek-de Kanter A; Mast M; Molenaar R; Kal HB; Lycklama à Nijeholt G; Vecht C; Struikmans H
    Strahlenther Onkol; 2012 Aug; 188(8):696-701. PubMed ID: 22722818
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Stereotactic radiosurgery of brain metastases: a retrospective study.
    Gruber I; Weidner K; Treutwein M; Koelbl O
    Radiat Oncol; 2023 Dec; 18(1):202. PubMed ID: 38115009
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Radiosurgery in the management of brain metastasis: a retrospective single-center study comparing Gamma Knife and LINAC treatment.
    Tuleasca C; Negretti L; Faouzi M; Magaddino V; Gevaert T; von Elm E; Levivier M
    J Neurosurg; 2018 Feb; 128(2):352-361. PubMed ID: 28338441
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Fractionated stereotactic radiotherapy of brain metastases from renal cell carcinoma.
    Ikushima H; Tokuuye K; Sumi M; Kagami Y; Murayama S; Ikeda H; Tanaka M; Oyama H; Shibui S; Nomura K
    Int J Radiat Oncol Biol Phys; 2000 Dec; 48(5):1389-93. PubMed ID: 11121638
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Single-dose versus fractionated stereotactic radiotherapy for brain metastases.
    Kim YJ; Cho KH; Kim JY; Lim YK; Min HS; Lee SH; Kim HJ; Gwak HS; Yoo H; Lee SH
    Int J Radiat Oncol Biol Phys; 2011 Oct; 81(2):483-9. PubMed ID: 20800386
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Gamma Knife surgery in the management of radioresistant brain metastases in high-risk patients with melanoma, renal cell carcinoma, and sarcoma.
    Powell JW; Chung CT; Shah HR; Canute GW; Hodge CJ; Bassano DA; Liu L; Mitchell L; Hahn SS
    J Neurosurg; 2008 Dec; 109 Suppl():122-8. PubMed ID: 19123898
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hypofractionated Stereotactic Radiation Therapy to the Resection Bed for Intracranial Metastases.
    Keller A; Doré M; Cebula H; Thillays F; Proust F; Darié I; Martin SA; Delpon G; Lefebvre F; Noël G; Antoni D
    Int J Radiat Oncol Biol Phys; 2017 Dec; 99(5):1179-1189. PubMed ID: 28974415
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Single-fraction radiosurgery versus fractionated stereotactic radiotherapy in patients with brain metastases: a comparative study.
    Loo M; Pin Y; Thierry A; Clavier JB
    Clin Exp Metastasis; 2020 Jun; 37(3):425-434. PubMed ID: 32185576
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impact of regular magnetic resonance imaging follow-up after stereotactic radiotherapy to the surgical cavity in patients with one to three brain metastases.
    Bachmann N; Leiser D; Ermis E; Vulcu S; Schucht P; Raabe A; Aebersold DM; Herrmann E
    Radiat Oncol; 2019 Mar; 14(1):45. PubMed ID: 30871597
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Outcomes and the Role of Primary Histology Following LINAC-based Stereotactic Radiation for Sarcoma Brain Metastases.
    Sim AJ; Ahmed KA; Keller A; Figura NB; Oliver DE; Sarangkasiri S; Robinson TJ; Johnstone PAS; Yu HM; Naghavi AO
    Am J Clin Oncol; 2020 May; 43(5):356-361. PubMed ID: 32217854
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Fractionated stereotactic radiotherapy for local control of resected brain metastases.
    Traylor JI; Habib A; Patel R; Muir M; Gadot R; Briere T; Yeboa DN; Li J; Rao G
    J Neurooncol; 2019 Sep; 144(2):343-350. PubMed ID: 31313060
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.